A case report of HLRCC syndrome combined Ⅳ inferior vena cava tumor thrombus
10.3760/cma.j.cn112330-20201102-00749
- VernacularTitle:HLRCC综合征合并Ⅳ级下腔静脉癌栓一例报告
- Author:
Kehao LI
1
;
Yuancheng DU
;
Xueping ZHANG
;
Changqing LIU
;
Li GE
;
Yongxiang LI
;
Liang QIAO
Author Information
1. 潍坊医学院临床医学院，山东潍坊 261053
- Keywords:
Carcinoma, Renal cell;
Hereditary leiomyomatosis;
Fumarate hydratase gene mutations
- From:
Chinese Journal of Urology
2021;42(10):782-783
- CountryChina
- Language:Chinese
-
Abstract:
Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome is a rare hereditary disease and characterized by cutaneous leiomyoma, uterine leiomyoma and/or renal cell carcinoma, but rarely associated with vena cava embolism. We treated 1 case of HLRCC syndrome patients with inferior vena cava tumor emboli (Mayo grade Ⅳ), confirmed after genetic testing, the patient and her family refused further treatment. The patient died after two months of follow-up after discharge.
